Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate PolyPid Ltd. before investing.

In this article, we go over a few key elements for understanding PolyPid Ltd.’s stock price such as:

• PolyPid Ltd.’s current stock price and volume
• Why PolyPid Ltd.’s stock price changed recently
• Upgrades and downgrades for PYPD from analysts
• PYPD’s stock price momentum as measured by its relative strength

About PolyPid Ltd. (PYPD)

Before we jump into PolyPid Ltd.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. The company is also developing OncoPLEX, which is in preclinical stage for the treatment of intra-tumoral cancer. The company has a research and development collaboration with ImmunoGenesis, Inc. for the development of formulations to treat solid tumors. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

Want to learn more about PolyPid Ltd.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about PolyPid Ltd..

PolyPid Ltd.’s Stock Price as of Market Close

As of October 29, 2026, 11:55 AM, CST, PolyPid Ltd.’s stock price was $5.700.

PolyPid Ltd. is down 1.38% from its previous closing price of $5.780.

During the last market session, PolyPid Ltd.’s stock traded between $5.590 and $5.840. Currently, there are approximately 22.64 million shares outstanding for PolyPid Ltd..

PolyPid Ltd.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

PolyPid Ltd. Stock Price History

PolyPid Ltd.’s (PYPD) price is currently up 8.16% so far this month.

During the month of October, PolyPid Ltd.’s stock price has reached a high of $5.840 and a low of $4.610.

Over the last year, PolyPid Ltd. has hit prices as high as $5.800 and as low as $3.500. Year to date, PolyPid Ltd.’s stock is up 31.34%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused PolyPid Ltd. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of October 28, 2026, there was 1 analyst who downgraded PolyPid Ltd.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate PolyPid Ltd.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on PolyPid Ltd.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about PolyPid Ltd. (PYPD) by visiting AAII Stock Evaluator.

Relative Price Strength of PolyPid Ltd.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of October 28, 2026, PolyPid Ltd. has a weighted four-quarter relative price strength of 13.53%, which translates to a Momentum Score of 89 and is considered to be Very Strong.

Want to learn more about how PolyPid Ltd. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

PolyPid Ltd. Stock Price: Bottom Line

As of October 29, 2026, PolyPid Ltd.’s stock price is $5.700, which is down 1.38% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like PolyPid Ltd. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.